Skip to content

百奥技术

US · TECH #1365 按市值排名 上市于 1970
72.57 +0.05 +0.07%
实时 - 追踪5344个代码 - 心跳于314秒前 · 2026-10-16 19:30

✦ 量化财务健康度 计算方式说明

良好
  • 奥特曼 Z 值为15.98,高于3.0的"安全区"阈值。
  • 该模型对工业和制造业公司最为可靠,对银行、保险等金融类公司参考意义较弱。

营收 年度数据,近8年

最近年度同比-0.38%

利润率

毛利率
65.77%
营业利润率
22.44%
净利率
14.97%

关键比率与质量指标

奥特曼 Z 值低于约1.8提示财务困境风险,高于约3.0提示风险较低;该模型对工业和制造业公司最为可靠,对银行等金融类公司参考意义较弱。

利润表

项目 2019 2020 2021 2022 2023 2024 2025 2026
营收 714.01M738.69M931.03M1.11B1.14B1.16B1.22B1.22B
毛利润 473.49M483.19M632.85M756.50M769.82M769.73M790.27M799.07M
销售及管理费用 236.87M240.88M289.92M339.00M352.44M393.32M415.10M406.67M
研发费用 62.41M65.19M70.60M87.14M92.49M96.66M99.50M94.77M
营业利润 147.10M148.85M242.69M295.83M291.00M246.40M242.80M272.61M
税前利润 112.02M276.48M148.18M301.39M338.66M185.69M98.46M240.68M
税费 15.94M47.18M8.59M38.29M53.22M17.58M25.06M58.82M
净利润 96.07M229.30M139.59M263.10M285.44M168.11M73.40M181.86M
基本每股收益 12122101
稀释每股收益 0.621.460.871.661.761.050.461.16

资产负债表

项目 2019 2020 2021 2022 2023 2024 2025 2026
流动资产总额 412.61M520.92M510.61M605.56M621.48M617.42M608.30M744.40M
现金及短期投资 166.03M270.89M231.55M247.03M204.31M152.86M162.19M264.71M
存货 91.05M103.15M116.75M141.12M171.64M179.73M189.45M195.74M
总资产 1.88B2.03B2.26B2.29B2.64B2.70B2.56B2.59B
流动负债总额 101.99M106.67M152.28M176.02M128.51M159.38M175.85M163.70M
短期负债 12.50M22.04M24.10M24.43M11.20M12.92M14.10M14.94M
长期负债 492.66M344.24M328.83M243.41M350.00M319.00M346.00M200.00M
总负债 718,821,000.00646,397,000.00691,723,000.00593,794,000.00672,176,000.00635,017,000.00639,060,000.00478,505,000.00
股东权益总额 1.17B1.38B1.57B1.70B1.97B2.07B1.92B2.11B
留存收益 931.93M1.06B1.09B1.12B1.31B1.33B1.07B1.14B

现金流量表

项目 2019 2020 2021 2022 2023 2024 2025 2026
经营活动现金流 181.62M205.22M352.16M325.27M254.39M298.98M287.56M292.07M
折旧与摊销 78.17M82.74M87.75M101.07M107.24M111.71M109.90M97.36M
自由现金流 156.21M153.47M307.86M280.36M216.15M236.10M256.55M263.22M
已派股息 -48.36M-48.90M-49.62M-50.19M-50.29M-50.42M-50.39M-49.92M
股票回购/发行 -15.41M-50.11M-43.18M-160.95M-19.56M-80.04M-275.73M-41.68M
期末现金余额 100.89M146.63M199.09M172.57M180.57M151.79M162.19M264.71M

回报与效率指标

项目 2019 2020 2021 2022 2023 2024 2025 2026
净资产收益率 8.5517.999.5316.6615.558.333.689.03
总资产收益率 5.5211.716.5411.9311.566.292.797.07
投入资本回报率 7.3614.038.0614.0213.127.303.177.81
5年平均净资产收益率 10.9011.8811.3613.0313.6613.6110.7510.65
息税前利润率 18.7340.0317.4128.2830.7817.388.7720.60
自由现金流/营收 21.8820.7833.0725.3619.0220.3721.0421.66
流动比率 4.054.883.353.444.843.873.464.55
速动比率 2.983.692.482.513.292.472.102.94
资产负债率 26.8121.3818.5814.2017.2415.5217.3611.18
长期负债权益比 42.2729.7925.3717.7222.5719.6522.4113.00
利息保障倍数 6.1615.4011.6227.6531.2012.8012.5725.99
营收复合年增长率(3年) 12.689.4813.1315.6915.457.583.332.25
净利润复合年增长率(3年) -2.7644.443.6341.487.556.18-35.38-13.93
自由现金流复合年增长率(3年) 7.076.0927.2421.5312.09-8.47-2.926.79

✦ 量化营收集中度 计算方式说明

单一主业
  • 在披露的4个业务分部中,Protein Sciences是最大的一项,占营收的71.98%。
  • 第二大业务Diagnostics and Spatial Biology占比仅27.68%,与第一名差距悬殊——若主业大幅放缓,几乎没有其他业务能够对冲。

营收构成 最近报告期

业务分部

Protein Sciences71.98%
Diagnostics and Spatial Biology27.68%
Other revenue0.45%

地区分部

United States52.29%
EMEA, excluding United Kingdom24.22%
Greater China8.56%
Asia Pacific, excluding Greater China7.06%
United Kingdom4.63%
Rest of world3.23%

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

百奥技术 讨论区 0 条评论

发表评论